Alterity Therapeutics Limited Stock
Stocks
ATH
AU0000043945
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6700 AUD | +3.08% |
|
+19.64% | +67.50% |
| Market Cap | 101M 88.35M 81.2M 75.69M 144M 9.62B 146M 975M 379M 4.73B 379M 371M 16.3B | P/E 2026 * |
-0.39x | P/E 2027 * | -0.39x |
|---|---|---|---|---|---|
| Enterprise Value | 55.88M 48.85M 44.89M 41.85M 79.37M 5.32B 80.57M 539M 210M 2.62B 210M 205M 9.01B | EV / Sales 2026 * |
21.8x | EV / Sales 2027 * | 50.1x |
| Free-Float |
91.47% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Alterity Therapeutics Limited
| 1 day | +3.08% | ||
| 1 week | +19.64% | ||
| Current month | +16.52% | ||
| 1 month | +48.89% | ||
| 3 months | +48.89% | ||
| 6 months | +48.89% | ||
| Current year | +67.50% |
| 1 week | 0.56 |  | 0.72 |
| 1 month | 0.45 | | 0.72 |
| Current year | 0.35 | | 0.72 |
| 1 year | 0.35 | | 0.85 |
| 3 years | 0.1 | | 0.95 |
| 5 years | 0.1 | | 2.05 |
| 10 years | 0.1 | | 20.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Stamler
CEO | Chief Executive Officer | 65 | 2021-01-06 |
Abby Niven
DFI | Director of Finance/CFO | - | 2024-09-29 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Peter Marks
BRD | Director/Board Member | 70 | 2005-07-28 |
Lawrence Gozlan
BRD | Director/Board Member | 47 | 2011-08-07 |
David Stamler
BRD | Director/Board Member | 65 | 2025-11-20 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-14 | Free | Chairman | 2,000,000 | 0.0184% | ||
| 06-14 | Free | Chairman | 2,000,000 | 0.0184% | ||
| 06-14 | Free | Director | 1,000,000 | 0.0092% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.08% | +19.64% | +48.89% | +123.33% | 101M | |
| +1.70% | +7.41% | +3.12% | +8.46% | 49.92B | |
| +0.92% | +3.93% | +399.71% | +605.33% | 40.23B | |
| +1.89% | +8.32% | +26.06% | -6.35% | 34.55B | |
| +2.38% | +6.35% | +21.25% | +64.58% | 33.09B | |
| +3.96% | +10.67% | +11.89% | +38.86% | 27.51B | |
| +2.51% | +5.27% | - | - | 17.05B | |
| +2.58% | +5.79% | +73.44% | +133.27% | 15.92B | |
| +0.32% | +0.58% | +13.67% | +19.09% | 13.86B | |
| +3.30% | +0.76% | +90.23% | +99.12% | 13.52B | |
| Average | +2.26% | +7.21% | +76.47% | +120.63% | 24.58B | |
| Weighted average by Cap. | +2.07% | +6.54% | +90.73% | +137.74% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.57M 2.25M 2.06M 1.92M 3.65M 245M 3.7M 24.77M 9.63M 120M 9.64M 9.43M 414M | 1.2M 1.05M 964K 899K 1.7M 114M 1.73M 11.58M 4.5M 56.18M 4.51M 4.41M 194M |
| Net income | -14.62M -12.78M -11.75M -10.95M -20.77M -1.39B -21.08M -141M -54.83M -684M -54.89M -53.71M -2.36B | -29.6M -25.88M -23.78M -22.17M -42.05M -2.82B -42.68M -286M -111M -1.39B -111M -109M -4.77B |
| Net Debt | -45.19M -39.5M -36.3M -33.84M -64.18M -4.3B -65.16M -436M -169M -2.11B -170M -166M -7.29B | -40.88M -35.74M -32.84M -30.61M -58.07M -3.89B -58.95M -394M -153M -1.91B -153M -150M -6.59B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-03 | A$0.6700 | +3.08% | 397,226 |
| 26-07-02 | A$0.6500 | -1.52% | 122,000 |
| 26-07-01 | A$0.6600 | +14.78% | 1,047,636 |
| 26-06-30 | A$0.5750 | +0.88% | 196,277 |
| 26-06-29 | A$0.5700 | +1.79% | 20,945 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ATH Stock
Select your edition
All financial news and data tailored to specific country editions
